Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Acta Pharmacol Sin
2010 Mar 01;313:297-306. doi: 10.1038/aps.2010.8.
Show Gene links
Show Anatomy links
Blocking effect of methylflavonolamine on human Na(V)1.5 channels expressed in Xenopus laevis oocytes and on sodium currents in rabbit ventricular myocytes.
Fan XR
,
Ma JH
,
Zhang PH
,
Xing JL
.
???displayArticle.abstract???
To investigate the blocking effects of methylflavonolamine (MFA) on human Na(V)1.5 channels expressed in Xenopus laevis oocytes and on sodium currents (I(Na)) in rabbit ventricular myocytes. Human Na(V)1.5 channels were expressed in Xenopus oocytes and studied using the two-electrode voltage-clamp technique. I(Na) and action potentials in rabbit ventricular myocytes were studied using the whole-cell recording. MFA and lidocaine inhibited human Na(V)1.5 channels expressed in Xenopus oocytes in a positive rate-dependent and concentration-dependent manner, with IC(50) values of 72.61 micromol/L and 145.62 micromol/L, respectively. Both of them markedly shifted the steady-state activation curve of I(Na) toward more positive potentials, shifted the steady-state inactivation curve of I(Na) toward more negative potentials and postponed the recovery of the I(Na) inactivation state. In rabbit ventricular myocytes, MFA inhibited I(Na) with a shift in the steady-state inactivation curve toward more negative potentials, thereby postponing the recovery of the I(Na) inactivation state. This shift was in a positive rate-dependent manner. Under current-clamp mode, MAF significantly decreased action potential amplitude (APA) and maximal depolarization velocity (V(max)) and shortened action potential duration (APD), but did not alter the resting membrane potential (RMP). The demonstrated that the kinetics of sodium channel blockage by MFA resemble those of class I antiarrhythmic agents such as lidocaine. MFA protects the heart against arrhythmias by its blocking effect on sodium channels.
Figure 1. MFA, plasmid and sodium current. (A) Diagram of the molecular structure of MFA. (B) Electrophoresis identification of the pcDNA 3.1 HA-SCN5A (NaV1.5) plasmid vector; Lane 1, the plasmid with Csp45 I restriction enzyme digestion; Lane 2, the pcDNA 3.1 HA-SCN5A (NaV1.5) plasmid vector. (C) Confirmation of INa. Depolarizing pulses from -120 mV to -40 mV for 100 ms were applied. Current tracings of human NaV1.5 channels expressed in Xenopus oocytes are superimposed before (control) and during superfusion of 20 μmol/L TTX.
Figure 2. Concentration-dependent blockage of INa by MFA or lidocaine. Depolarizing pulses from -120 mV to -40 mV for 100 ms were applied. (A) Current tracings of human NaV1.5 channels expressed in Xenopus oocytes are superimposed before (control) and during superfusion of MFA (5–250 μmol/L) or lidocaine (5–750 μmol/L). (B) The concentration-response curves are plotted based on data from panel A and fitted by the Hill equation. (C) Time-course of the effects of MFA on human NaV1.5 channels expressed in Xenopus oocytes. Oocytes were perfused with ND96 solution for 5 min before application of 100 μmol/L MFA or without drug and again with ND96 solution (washout). The normalized currents are plotted during the recording course. (D) The effects of MFA on the current-voltage relationship of human NaV1.5 channels expressed in Xenopus oocytes. Depolarizing pulses (100 ms duration) were applied from a holding potential of -120 mV to various potentials ranging from -100 mV to +40 mV with 5 mV increments.
Figure 3. Effects of MFA or lidocaine on steady-state activation and inactivation of INa in Xenopus oocytes. The activation protocol was obtained from the current-voltage relationship (100-ms depolarizing pulses to potentials ranging from -70 mV to -20 mV in 5 mV increments), and the inactivation curve was obtained using of a double-pulse protocol (100-ms conditioning prepulses from a holding potential of -100 mV to -40 mV in 5 mV increments), followed by a test pulse to -10 mV for 100 ms. (A and B) The activation and inactivation currents of human NaV1.5 channels expressed in Xenopus oocytes before and after superfusion of 100 μmol/L MFA or 250 μmol/L lidocaine, respectively. (C) The normalized steady-state activation and inactivation of human NaV1.5 channels expressed in Xenopus oocytes plotted in the absence and presence of 100 μmol/L MFA or 250 μmol/L lidocaine.
Figure 4. Effects of MFA or lidocaine on recovery from inactivation of INa in Xenopus oocytes. The recovery from inactivation was studied using a conventional double-pulse protocol (a 50-ms prepulse to -40 mV from a holding potential of -120 mV, followed by a variable recovery period from 2–80 ms and then by a test pulse to -40 mV for 50 ms). (A) Example tracing of the recovery from inactivation of human NaV1.5 channels expressed in Xenopus oocytes before and after superfusion of 100 μmol/L MFA or 250 μmol/L lidocaine. (B) The normalized recovery from inactivation of human NaV1.5 channels expressed in Xenopus oocytes plotted in the absence and presence of 100 μmol/L MFA or 250 μmol/L lidocaine.
Figure 5. Rate-dependent blockage of INa by MFA or lidocaine in Xenopus oocytes. A series of 30 depolarizing pulses with 30 ms duration from a holding potential of -120 mV to -40 mV at different stimulation frequencies was applied to rabbit ventricular myocytes. After stimulating at each frequency, cells were perfused with normal solution, and INa recovered substantially. (A and C) Superimposed tracings of INa obtained from different experiments: in control at 4 Hz, and in the presence of 75 μmol/L MFA or 250 μmol/L lidocaine at 1 Hz, 2 Hz and 4 Hz. (B and D) Relative INa was plotted against each pulse number. Relative INa was defined as the ratio of INa at each pulse number/INa at the first pulse.
Figure 6. Onset of INa blockage by MFA in Xenopus oocytes. Prepulses of various durations (1−100 ms) were applied to -30 mV from a holding potential of -120 mV, after a 250 ms recovery period at -120 mV and after a 20 ms test pulse was applied again to -30 mV. (A) Current tracings of human NaV1.5 channels expressed in Xenopus oocytes before and after superfusion of 100 μmol/L MFA. (B) The normalized onset blockage of INa in Xenopus oocytes plotted in the absence and presence of 100 μmol/L MFA.
Figure 7. Effects of MFA on current-voltage relationship, steady state activation and inactivation of INa in rabbit ventricular myocytes. The pulse protocols were as described in Figures 2 and 3. (A) Sodium current tracings of rabbit ventricular myocytes superimposed before (control), during superfusion of MFA 75 μmol/L and after washout. (B and C) Activation and inactivation currents of rabbit ventricular myocytes before and after superfusion of 100 μmol/L MFA, respectively. (D–F) The effects of 100 μmol/L MFA on the current-voltage relationship, steady-state activation and inactivation curves of INa in rabbit ventricular myocytes, respectively.
Figure 8. Effects of MFA on the recovery from inactivation and rate-dependent blockage of INa in rabbit ventricular myocytes. The clamp protocols were as described in Figures 4 and 5. (A and C) Current tracings of rabbit ventricular myocytes before and after superfusion of 100 or 75 μmol/L MFA, respectively. For reasons of clarity, only the first (P1) and the last (P30) currents are shown. (B and D) Normalized INa was plotted in the absence and presence of 100 or 75 μmol/L MFA and against the recovery time or each pulse number, respectively.
Figure 9. Effects of MFA on AP characteristics in rabbit ventricular myocytes. APs were elicited by depolarizing pulses delivered for 5 ms and at 1.5-fold above the threshold at a rate of 1 Hz. Representative recordings of APs are superimposed before (control), during superfusion of MFA 75 μmol/L and after washout.
Balser,
Structure and function of the cardiac sodium channels.
1999, Pubmed
Balser,
Structure and function of the cardiac sodium channels.
1999,
Pubmed
Bean,
Lidocaine block of cardiac sodium channels.
1983,
Pubmed
Campbell,
Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification.
1983,
Pubmed
Catterall,
From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.
2000,
Pubmed
Chen,
[Anti-arrhythmic action of 4'-methyl-7-([2-hydroxy-3-(beta-propinamidoethyl)amino]propoxy) flavone hydrochloride (SIPI-644)].
1988,
Pubmed
Coromilas,
Classification of antiarrhythmic agents: electropharmacologic basis and clinical relevance.
1992,
Pubmed
Dun,
[Anti-arrhythmia and anti-lipid peroxidation effects of methylflavonolamine].
1991,
Pubmed
Fahmi,
The sodium channel beta-subunit SCN3b modulates the kinetics of SCN5a and is expressed heterogeneously in sheep heart.
2001,
Pubmed
,
Xenbase
Furukawa,
An analysis of lidocaine block of sodium current in isolated human atrial and ventricular myocytes.
1995,
Pubmed
Guo,
[Effects of methylflavonolamine hydrochloride on physiologic properties of isolated guinea pig atrium].
1989,
Pubmed
Haigney,
Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading.
1994,
Pubmed
Han,
[The effect of 4'-methyl-7-(2-hydroxy-3-isopropylamino-propoxy)-flavone hydrochloride (SIPI-549) on coronary blood flow and experimental myocardial infarction in rabbits].
1986,
Pubmed
Han,
[Anti-arrhythmic effects of methylflavonolamine hydrochloride].
1987,
Pubmed
Iwai,
Protective effect of propranolol on mitochondrial function in the ischaemic heart.
2002,
Pubmed
Ji,
Puerarin inhibits tetrodotoxin-resistant sodium current in rat dorsal root ganglion neurons.
1996,
Pubmed
Johnson,
Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating.
2006,
Pubmed
Paillart,
Direct block of voltage-sensitive sodium channels by genistein, a tyrosine kinase inhibitor.
1997,
Pubmed
Pierce,
The contribution of ionic imbalance to ischemia/reperfusion-induced injury.
1995,
Pubmed
Pinet,
Thrombin facilitation of voltage-gated sodium channel activation in human cardiomyocytes: implications for ischemic sodium loading.
2002,
Pubmed
Sanchez-Chapula,
Voltage- and use-dependent effects of lidocaine on sodium current in rat single ventricular cells.
1983,
Pubmed
Wang,
State-dependent block of wild-type and inactivation-deficient Na+ channels by flecainide.
2003,
Pubmed
Wang,
[Central action of anti-arrhythmic effect of methylflavonolamine hydrochloride].
1987,
Pubmed
Weirich,
[Current classification of anti-arrhythmia agents].
2000,
Pubmed
Weirich,
Rate-dependence of antiarrhythmic and proarrhythmic properties of class I and class III antiarrhythmic drugs.
1998,
Pubmed
Wood,
Voltage-gated sodium channels.
2001,
Pubmed
Xiao,
Electrophysiologic properties of lidocaine, cocaine, and n-3 fatty-acids block of cardiac Na+ channels.
2004,
Pubmed
Yin,
[Beta-adrenergic receptor blocking action of methylflavonolamine hydrochloride].
1987,
Pubmed
Zhang,
Puerarin blocks Na+ current in rat ventricular myocytes.
2003,
Pubmed
Zhang,
Methylflavonolamine hydrochloride inhibits contractions induced by noradrenaline, calcium and potassium in rabbit isolated aortic strips.
1988,
Pubmed
Zhang,
Methylflavonolamine protects aorta from atherosclerosis in cholesterol-fed rabbits.
1993,
Pubmed
